Home > Healthcare > Medical Devices > Infection Control > Endoscope Reprocessing Market

Endoscope Reprocessing Market Size

  • Report ID: GMI10131
  • Published Date: Jul 2024
  • Report Format: PDF

Endoscope Reprocessing Market Size

Endoscope Reprocessing Market size was valued at around USD 2.9 billion in 2023 and is estimated to grow at 11.5% CAGR from 2024 to 2032. The rising prevalence of gastrointestinal diseases, cancer, and other medical conditions requiring diagnostic and therapeutic endoscopic procedures is a significant driver for the market.

 

For instance, according to an article published in 2024 by the American Society of Anesthesiologists, approximately 6.1 million upper endoscopies are performed annually in the U.S. As endoscopic procedures become more common for both diagnostic and interventional purposes, the need for effective and efficient reprocessing of endoscopes and accessories also increases.
 

Moreover, the focus on effective reprocessing of endoscopes is driven by the need to enhance patient safety and reduce the risk of healthcare-acquired infections. Regulatory bodies and organizations issue stringent guidelines to ensure the reliability of reprocessing procedures. With the rise of multidrug-resistant pathogens and increased scrutiny on infection control, thorough cleaning, disinfection, and validation processes are essential, hence driving the market growth.
 

Endoscope reprocessing is the systematic process of cleaning, disinfecting, and sterilizing endoscopes to ensure they are safe for reuse. This process includes several stages such as pre-cleaning, leak testing, manual cleaning, high-level disinfection or sterilization, rinsing, and drying. It is crucial for preventing cross-contamination and healthcare-associated infections.
 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global endoscope reprocessing delivery industry was valued at USD 2.9 billion in 2023 and is anticipated to register 11.5% CAGR between 2024 and 2032, driven by the rising prevalence of gastrointestinal diseases, cancer, and other medical conditions.

The devices segment in the market was valued at USD 1.9 billion in 2023, owing to the growing use of endoscopic procedures in diagnostic and therapeutic applications.

North America endoscope reprocessing market is poised to reach USD 3.2 billion by 2032, attributed to the increasing incidence of gastrointestinal diseases, cancers, and other chronic conditions.

ARC Group of Companies Inc., ASP, Belimed, CONMED Corporation, Creo Medical, Ecolab, Getinge AB, Karl Storz, Metrex Research, LLC., and Olympus Corporation, among others.

Endoscope Reprocessing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 243
  • Countries covered: 36
  • Pages: 100
 Download Free Sample